An announcement from Monopar Therapeutics Inc ( (MNPR) ) is now available.
Monopar Therapeutics Inc. announced the resignation of Michael J. Brown from its Board of Directors effective February 19, 2025, and the appointment of Lavina Talukdar to the Board on February 21, 2025. Talukdar, who is currently the Senior Vice President, Head of Investor Relations at Moderna Inc., brings over 20 years of experience in investor relations and healthcare investments. Her appointment is expected to enhance Monopar’s strategic direction and governance, as she will also serve on several key committees within the company.
More about Monopar Therapeutics Inc
YTD Price Performance: 81.14%
Average Trading Volume: 76,009
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $245.6M
See more insights into MNPR stock on TipRanks’ Stock Analysis page.